Northwire Canada EditionFriday, July 10, 2026
Northwire
FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.38 +7.6% TUNG 1.72 +1.8% LGO 1.01 −2.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.30 −2.0% SGZ 0.045 +0.0% S 0.135 +12.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.73 −0.9% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.38 +7.6% TUNG 1.72 +1.8% LGO 1.01 −2.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.30 −2.0% SGZ 0.045 +0.0% S 0.135 +12.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.73 −0.9%
Financings Material −

iFabric boosts bought deal offering, secondary offering

iFabric’s record quarter swiftly followed by upsized share dump and insider cash‑out.

Executive Summary

The most recent disclosure (May 14 2026) is the upsizing of a bought‑deal offering first announced the prior day. The combined treasury + secondary offering now totals $25,004,600, up from the original $20 million.
- Treasury portion: 5,406,000 new shares at $3.70 – raising $20.0 million for the company (41 % larger than the initial 4.055 million shares).
- Secondary portion: 1,352,000 shares offered by founders Hylton and Susan Karon at the same $3.70 price, grossing $5.0 million for the selling shareholders.
- Over‑allotment option adds up to 15 % more treasury shares ($3.0 million extra).
- Post‑closing, the founders’ stake drops from 63.3 % to 50.0 %.
- Closing is expected on or about June 4 2026.

Immediately before the offering, iFabric reported record Q1 2026 earnings (May 12):
- Revenue $27.5 million (+288 % YoY), net income $3.71 million ($0.122/share).
- Intelligent Fabrics (scrubs, footwear) delivered $23.6 million, while the new Nudish intimate‑apparel brand added $3.9 million.
- Gross margin contracted to 33 % (from 39 %) on product mix and tariffs; adjusted EBITDA $5.7 million.
- Cash only $1.76 million, working capital $23.8 million – pointing to the need for fresh capital.

Earlier in 2026 the company launched Roots ® footwear (~$8 million expected annual revenue), Frontline ™ scrubs at Costco Canada, the Lad Collective bedding partnership, and a Doctor’s Choice ® scrubs license – all contributing to the revenue surge.

Material Impact

The equity raise, particularly the upsizing, brings clear negative elements: - Dilution: The treasury shares alone increase the share count by ~17.7 %, and the over‑allotment could push it higher. Existing shareholders are diluted at a price ($3.70) that is a discount to the prevailing market (around $4.00). - Insider sell‑down: Founders are reducing their combined stake from 63.3 % to 50.0 %, pocketing $5 million. While they retain control, the size and timing (right after record results) signal that the largest shareholders view the post‑rally price as an opportune exit point. - Market reaction: The stock slipped from $4.13 on the earnings day to $4.05 when the initial offering was announced, and further to $4.00 when it was upsized. This sequential decline suggests the market interprets the funding – and especially the secondary offering – as a drag on sentiment. - Essential capital: On the other hand, the company needed the money. With only $1.76 million in cash and heavy inventory ($21 million) to support its explosive growth, external financing was almost unavoidable. The $20 million treasury injection will fund product development, marketing, and working capital, enabling continued execution of the high‑growth Walmart, Costco, and intimate‑apparel programs.

Taken together, the proceeds are necessary but come at a material cost to existing holders: dilution and a clear insider sell signal. The net impact is Material – Negative.

IFA · Price
Company Overview

iFabric Corp. (TSX:IFA) operates through Intelligent Fabric Technologies (North America) Inc. (IFTNA) and its Coconut Grove intimate‑apparel division. The company develops and sells performance textiles enhanced with proprietary PROTX2 ® (antimicrobial, anti‑odor) and ecoPEL ™ (fluorine‑free durable water repellent) finishes.

Flagship growth driver: Clinically‑proven medical scrubs. A peer‑reviewed Journal of Hospital Infection study validated PROTX2’s bacterial reduction in real‑world healthcare settings. This technology underpins: - Walmart’s nationwide scrubs program (expanded by 1,000 additional stores in early 2026). - Frontline ™ scrubs at Costco Canada. - Doctor’s Choice ® branded scrubs via a license with Mercury Athletics. - Roots ®‑branded footwear (launched in Canada through a wholesale club retailer, targeting $8 million in first‑year revenue).

Additionally, iFabric replaced the expiring Maidenform license with its own Nudish ™ intimate‑apparel brand, saving ~10 % in royalties and gaining design freedom. The intimate‑apparel division is now in a growth phase, with sell‑through rates 100‑200 % above initial plans.

The company is also pursuing non‑apparel opportunities such as bedding (The Lad Collective partnership) and has signaled interest in hard‑surface coatings, hospitality, and defense.

Read the original news release →

More from iFabric Corp